Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
13 participants
INTERVENTIONAL
2007-10-31
2010-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Oasis Ultra in Diabetic Foot Ulcers
NCT01835379
Effect of Oasis® Wound Matrix on Stage III and IV Trunk Pressure Wounds Treated With Negative Pressure Wound Therapy
NCT02246608
The Effect of OASIS Ultra on Critical Sized Wound Healing
NCT01848821
Oasis Donor Site Wounds Post-Market Study
NCT04079348
Treatment of Wounds Using Oasis® ECM
NCT03632031
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
OASIS Wound Matrix (Oasis)
This is a single arm study with only the test article Oasis used on all subjects
OASIS Wound Matrix
OASIS (an acellular biomaterial that supports tissue repair with a scaffold-like matrix having a natural structure and composition).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
OASIS Wound Matrix
OASIS (an acellular biomaterial that supports tissue repair with a scaffold-like matrix having a natural structure and composition).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Healthpoint
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Healthpoint, Ltd.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
W. Payne, M.D.
Role: PRINCIPAL_INVESTIGATOR
Bay Pines VA Healthcare System
Carl Van Gils, DPM, CWS
Role: PRINCIPAL_INVESTIGATOR
Dixie Regional Medical Center Wound Clinic
Davin Haraway, DO
Role: PRINCIPAL_INVESTIGATOR
Sparks Regional Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sparks Regional Medical Center
Fort Smith, Arkansas, United States
Bay Pines VA Healthcare System
St Louis, Missouri, United States
Dixie Regional Medical Center Wound Clinic
St. George, Utah, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
9310-002-004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.